CareLit · DOI-Nachweis · Klinische Pädiatrie
The JARID1C histone demethylase is upregulated in aggressive neuroblastomas independent of MYCN amplification
DOI 10.1055/s-0032-1310494
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Fielitz, B Schowe, JH Schulte, J Vandesompele, P Mestdagh, A Eggert, K Morik, A Schramm
ZeitschriftKlinische Pädiatrie
Ausgabe04/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Defining reliable risk factors for progression and outcome in advanced stage neuroblastoma (NB) patients not harboring a MYCN amplification is still challenging. Methods: Expression profiles were generated from 113 primary NBs on Affymetrix microarrays. Genes associated with patient outcome but independent of known risk factors were identified using correlation analysis. Results: Expression of JARID1C was sign…
Zitieren
Zitierempfehlung
K Fielitz, B Schowe, JH Schulte, J Vandesompele, P Mestdagh, A Eggert, K Morik, A Schramm (2012) The JARID1C histone demethylase is upregulated in aggressive neuroblastomas independent of MYCN amplification. Klinische Pädiatrie (04). https://doi.org/10.1055/s-0032-1310494
Mit CareLit weiterarbeiten